Haghighi B, Yanagihara R, Cornbleet P J
Stanford University Medical Center, Department of Pathology, California 94305, USA.
Am J Hematol. 1998 Dec;59(4):302-8. doi: 10.1002/(sici)1096-8652(199812)59:4<302::aid-ajh6>3.0.co;2-z.
Immunoglobulin (Ig)M myeloma is a distinct subtype of multiple myeloma (MM) displaying clinical and pathologic features of both MM and Waldenström's macroglobulinemia (WM). Although the immunophenotypic characteristics of classic MM and WM have been reported, the surface antigen expression of IgM myeloma has not been reported. We report a case of IgM myeloma and describe its immunophenotypic profile using flow cytometry. The cells showed a hybrid MM-WM phenotype, strongly expressing CD38 but lacking CD45 and DR, typical for plasma cells; however, pan-B cell antigens CD20 and FMC7 as well as weak monoclonal surface Ig also were positive, resembling B-cell lymphoproliferative malignancies. Discordant B-cell antigen expression was present, in that pan-B antigens CD19 and CD22 were absent. In addition, B-cell activation antigen CD23, early B-precursor antigen CD10, and pan-T antigen CD5 were not expressed. Although CD20 and weak surface Ig expression have been reported in MM, FMC7 positivity has not been seen. The data therefore suggest that IgM myeloma may have a unique phenotype with characteristics of both MM and WM.
免疫球蛋白(Ig)M型骨髓瘤是多发性骨髓瘤(MM)的一种独特亚型,兼具MM和华氏巨球蛋白血症(WM)的临床及病理特征。尽管经典MM和WM的免疫表型特征已有报道,但IgM型骨髓瘤的表面抗原表达尚未见报道。我们报告1例IgM型骨髓瘤病例,并运用流式细胞术描述其免疫表型特征。细胞呈现出MM-WM混合表型,强烈表达浆细胞典型的CD38,但缺乏CD45和DR;然而,全B细胞抗原CD20和FMC7以及弱阳性的单克隆表面免疫球蛋白也呈阳性,类似于B细胞淋巴增殖性恶性肿瘤。存在不一致的B细胞抗原表达,即缺乏全B抗原CD19和CD22。此外,B细胞活化抗原CD23、早期B前体抗原CD10以及全T抗原CD5均未表达。尽管MM中已有CD20和弱阳性表面免疫球蛋白表达的报道,但尚未见FMC7阳性。因此,这些数据提示IgM型骨髓瘤可能具有兼具MM和WM特征的独特表型。